Summit to Spotlight Growing Sector

Posted: Updated:

About 250 industry and education leaders are set to take part in today's Indiana Life Sciences Summit. The 11th annual event will feature sessions on accelerating research, attracting capital and commercialization. BioCrossroads Chief Executive Officer David Johnson says the summit will also include an update on the Indiana Biosciences Research Institute, including efforts to recruit talent, a location and fundraising. Inside INdiana Business Host Gerry Dick will moderate two panels at today's event.

Indiana Life Sciences Summit Agenda

Wednesday, October 15 agenda includes:

Keynote Address: Christopher P. Austin, M.D., Director of National Center for Advancing Translational Sciences

Panel I: Exploring New Avenues to Accelerate Research

Moderator: Debra Lappin, Principal, Faegre Baker Daniels Consulting and President, Council for American Medical Innovation

Michael D. Clayman, M.D., CEO, Flexion Therapeutics

Annalisa Jenkins, MBBS, MRCP, CEO, Dimension Therapeutics

Jack Phillips, President and CEO, Roche Diagnostics

Pete Yonkman, President, Cook Medical

Panel II: Indiana Biosciences Research Institute's Approach to Quicker Commercialization

Moderator: Gerry Dick, President and Managing Editor, Grow INdiana Ventures / Host and Creator of Inside Indiana Business with Gerry Dick

David Broecker, COO, Indiana Biosciences Research Institute

Andrew M. Dahlem, D.V.M. (h.c.) Ph.D., Vice President, LRL Operations / LRL Europe, Eli Lilly and Company

Jay Hess, M.D., Ph.D., M.H.S.A., Dean, Indiana University School of Medicine; Vice President for University Clinical Affairs, Indiana University

Luke Kenley, Senator, Indiana State Senate

Panel III: The Need for Capital and its Impact on Innovation and Research

Moderator: Gerry Dick, President and Managing Editor, Grow INdiana Ventures / Host and Creator of Inside Indiana Business with Gerry Dick

Representative from Battelle Technology Partnership

Nadim Barakat, Managing Director, Carlyle Group

Mark Skinner, Vice President of the State Sciences & Technology Institute

Derek Small, Co-Founder and Executive Chairman, Assembly Pharmaceuticals

Don't miss this unique opportunity to network and learn more about the future of Indiana's life sciences industry which accounts for a $55 billion impact on our economy, employs more than 58,000 Hoosiers, and exports nearly $10 billion worth of new products each year.

Source: BioCrossroads